Passage Bio (PASG) is the lead sponsor of 1 active clinical trials listed on ClinicalTrials.gov[3], including 1 Phase 2[1], 1 Phase 1[2].
PASG has 2 Form 4 insider filings recorded at the SEC in the past 30 days[4].
PASG is tracked by BiotechSigns with a current catalyst score of 35/100 and grade D. The page summarizes 0 active signals, including 0 PDUFA, 0 insider buying, and 0 clinical trial signals, with data refreshed on 2026-06-03.
Passage Bio (PASG) is the lead sponsor of 1 active clinical trials listed on ClinicalTrials.gov[3], including 1 Phase 2[1], 1 Phase 1[2].
PASG has 2 Form 4 insider filings recorded at the SEC in the past 30 days[4].